.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Cerilliant
Deloitte
Novartis
Farmers Insurance
Medtronic
Dow
Harvard Business School
Federal Trade Commission
Fish and Richardson

Generated: June 24, 2017

DrugPatentWatch Database Preview

MIRTAZAPINE Drug Profile

« Back to Dashboard

Which patents cover Mirtazapine, and what generic Mirtazapine alternatives are available?

Mirtazapine is a drug marketed by Impax Labs Inc, Actavis Labs Fl Inc, Actavis Elizabeth, Watson Labs, Teva, Upsher-smith Labs, Aurobindo, Mylan, Sun Pharm Inds Inc, Ivax Sub Teva Pharms, Apotex Inc, Roxane, Aurobindo Pharma Ltd, Mylan Pharms Inc, and Zydus Pharms Usa Inc. and is included in twenty NDAs.

The generic ingredient in MIRTAZAPINE is mirtazapine. There are eighteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the mirtazapine profile page.

Summary for Tradename: MIRTAZAPINE

Patents:0
Applicants:15
NDAs:20
Suppliers / Packagers: see list44
Bulk Api Vendors: see list77
Clinical Trials: see list70
Patent Applications: see list2,959
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MIRTAZAPINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth
MIRTAZAPINE
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL077959-003Feb 14, 2011DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds Inc
MIRTAZAPINE
mirtazapine
TABLET;ORAL076541-004Apr 22, 2004ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
MIRTAZAPINE
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL077376-003Dec 8, 2005ABRXNoNo► Subscribe► Subscribe
Zydus Pharms Usa Inc
MIRTAZAPINE
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL205798-001Jun 1, 2017ABRXNoNo► Subscribe► Subscribe
Roxane
MIRTAZAPINE
mirtazapine
TABLET;ORAL076270-001Jun 19, 2003DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Deloitte
Colorcon
Moodys
Teva
Daiichi Sankyo
US Department of Justice
AstraZeneca
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot